The cell cycle: a critical therapeutic target to prevent vascular proliferative disease

T Charron, N Nili, BH Strauss - Canadian Journal of Cardiology, 2006 - Elsevier
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …
被引用次数：59 相关文章

The cell cycle: A critical therapeutic target to prevent vascular proliferative disease

T Charron, N Nili, BH Strauss - Canadian Journal of Cardiology, 2006 - infona.pl
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …

The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

T Charron, N Nili, BH Strauss - The Canadian Journal of Cardiology, 2006 - europepmc.org
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …

The cell cycle: a critical therapeutic target to prevent vascular proliferative disease

T Charron, N Nili, BH Strauss - The Canadian journal …, 2006 - pubmed.ncbi.nlm.nih.gov
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …
[PDF] academia.edu

[PDF][PDF] The cell cycle: A critical therapeutic target to prevent vascular proliferative disease

Can J Cardiol, 2006 - academia.edu
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …
[HTML] nih.gov

[HTML][HTML] The cell cycle: A critical therapeutic target to prevent vascular proliferative disease

T Charron, N Nili, BH Strauss - The Canadian Journal of …, 2006 - ncbi.nlm.nih.gov
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …

The cell cycle: a critical therapeutic target to prevent vascular proliferative disease.

T Charron, N Nili, BH Strauss - The Canadian Journal of Cardiology, 2006 - europepmc.org
Percutaneous coronary intervention is the preferred revascularization approach for most
patients with coronary artery disease. However, this strategy is limited by renarrowing of the …

[引用][C] The cell cycle: A critical therapeutic target to prevent vascular proliferative disease

T CHARRON, N NILI, BH STRAUSS - Canadian journal of cardiology, 2006 - Pulsus